Interestingly, the combination of WNT974 and ART significantly reduced KRAS protein levels (Fig. 1B) but did not affect NRAS and HRAS (Fig. 1B) in the CRC cells when compared to WNT974 or ART mono-treatments. This evidence concerns the gene KRAS and colorectal carcinoma.